Black Diamond Therapeutics Financial Statements (BDTX)

Black Diamond Therapeuticssmart-lab.ru %   2019 2020 2021 2022 2023   LTM ?
Report date 24.03.2020 25.03.2021 17.03.2022 09.03.2023 12.03.2024   09.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 0.000 0.000 0.000 0.000 0.000   4.89
Operating Income, bln rub -8.90 -69.6 -126.9 -92.8 -86.5   -85.1
EBITDA, bln rub ? -22.9 -67.3 -125.6 -95.1 -86.0   -84.9
Net profit, bln rub ? -41.1 -65.5 -123.2 -84.5 -82.4   -79.8
OCF, bln rub ? -24.7 -52.1 -100.1 -85.1 -66.7   -67.9
CAPEX, bln rub ? 0.021 0.142 2.71 0.192 0.033   0.066
FCF, bln rub ? -24.7 -52.3 -102.9 -85.3 -66.8   -67.9
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 29.3 69.6 126.9 92.8 86.0   85.0
Cost of production, bln rub 0.047 0.600 2.22 3.24 0.437   1.81
R&D, bln rub 21.8 48.2 96.8 64.4 58.9   58.0
Interest expenses, bln rub 0.000 0.001 0.000 3.91 0.000   0.686
Assets, bln rub 158.3 329.7 247.7 156.3 158.6   142.5
Net Assets, bln rub ? -51.0 -118.2 -243.8 -335.0 116.7   104.3
Debt, bln rub 200.6 8.74 28.5 28.1 25.3   24.5
Cash, bln rub 154.7 315.1 209.8 122.8 131.4   115.2
Net debt, bln rub 45.9 -306.3 -181.3 -94.7 -106.1   -90.7
Ordinary share price, rub 32.1 5.33 1.80 2.81   1.80
Number of ordinary shares, mln 35.9 32.9 36.2 36.3 44.0   51.8
Market cap, bln rub 0 1 055 193 65 124   93
EV, bln rub ? 46 748 12 -29 17   3
Book value, bln rub -51 -118 -244 -335 117   104
EPS, rub ? -1.15 -1.99 -3.40 -2.33 -1.88   -1.54
FCF/share, rub -0.69 -1.59 -2.84 -2.35 -1.52   -1.31
BV/share, rub -1.42 -3.59 -6.74 -9.22 2.66   2.01
EBITDA margin, % ?   -1 734%
Net margin, % ?   -1 630%
FCF yield, % ? -4.96% -53.3% -130.4% -54.0%   -72.8%
ROE, % ? 80.7% 55.4% 50.5% 25.2% -70.6%   -76.5%
ROA, % ? -26.0% -19.9% -49.7% -54.1% -52.0%   -56.0%
P/E ? 0.00 -16.1 -1.57 -0.77 -1.50   -1.17
P/FCF 0.00 -20.2 -1.88 -0.77 -1.85   -1.37
P/S ?   19.1
P/BV ? 0.00 -8.92 -0.79 -0.20 1.06   0.89
EV/EBITDA ? -2.00 -11.1 -0.09 0.31 -0.20   -0.03
Debt/EBITDA -2.00 4.55 1.44 1.00 1.23   1.07
R&D/CAPEX, % 103 586% 33 950% 3 573% 33 561% 178 524%   87 833%
CAPEX/Revenue, %   1.35%
Black Diamond Therapeutics shareholders